CN103966312B - Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application - Google Patents
Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application Download PDFInfo
- Publication number
- CN103966312B CN103966312B CN201410102233.2A CN201410102233A CN103966312B CN 103966312 B CN103966312 B CN 103966312B CN 201410102233 A CN201410102233 A CN 201410102233A CN 103966312 B CN103966312 B CN 103966312B
- Authority
- CN
- China
- Prior art keywords
- real
- peripheral blood
- gene fragment
- recombinant plasmid
- target gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 59
- 239000013612 plasmid Substances 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 31
- 210000005259 peripheral blood Anatomy 0.000 title claims abstract description 24
- 239000011886 peripheral blood Substances 0.000 title claims abstract description 24
- 210000004698 lymphocyte Anatomy 0.000 title claims abstract description 20
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 title claims abstract 9
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 title claims abstract 9
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 title claims abstract 8
- 238000010276 construction Methods 0.000 title claims description 5
- 238000011897 real-time detection Methods 0.000 title abstract description 7
- 239000012634 fragment Substances 0.000 claims abstract description 34
- 238000004458 analytical method Methods 0.000 claims abstract description 13
- 239000002299 complementary DNA Substances 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims abstract description 10
- 238000012163 sequencing technique Methods 0.000 claims abstract description 9
- 238000012408 PCR amplification Methods 0.000 claims abstract description 7
- 238000000246 agarose gel electrophoresis Methods 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 7
- 238000003753 real-time PCR Methods 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 230000002441 reversible effect Effects 0.000 claims description 14
- 238000004925 denaturation Methods 0.000 claims description 7
- 230000036425 denaturation Effects 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000000137 annealing Methods 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 6
- 108010006785 Taq Polymerase Proteins 0.000 claims description 4
- 230000008859 change Effects 0.000 abstract description 9
- 238000010839 reverse transcription Methods 0.000 abstract description 8
- 230000007170 pathology Effects 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 230000004907 flux Effects 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000000527 lymphocytic effect Effects 0.000 abstract 1
- 241000710777 Classical swine fever virus Species 0.000 description 39
- 208000015181 infectious disease Diseases 0.000 description 22
- 230000003321 amplification Effects 0.000 description 16
- 238000003199 nucleic acid amplification method Methods 0.000 description 16
- 238000001514 detection method Methods 0.000 description 14
- 230000003612 virological effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 241000282887 Suidae Species 0.000 description 8
- 208000001726 Classical Swine Fever Diseases 0.000 description 7
- 108010002350 Interleukin-2 Proteins 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000001506 immunosuppresive effect Effects 0.000 description 6
- 238000004445 quantitative analysis Methods 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000019491 signal transduction Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000006058 immune tolerance Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013373 clone screening Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000003832 immune regulation Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- -1 carboxyl Fluorescein diacetate succinimidyl ester Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000005860 defense response to virus Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004237 neck muscle Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007414 peripheral immune response Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010807 real-time PCR kit Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明属于分子病理学与免疫学技术领域,具体涉及猪外周血单核淋巴细胞PD-L2重组质粒的构建、基因丰度实时检测方法及其应用。 The invention belongs to the technical field of molecular pathology and immunology, and specifically relates to the construction of a PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, a real-time detection method for gene abundance and an application thereof.
背景技术 Background technique
猪瘟(Classicalswinefever,CSF)是由猪瘟病毒(Classicalswinefevervirus,CSFV)引起的一种急性、热性、高度接触性传染病。研究表明,CSFV主要感染单核-巨噬细胞系统,引起严重的淋巴细胞减少、血小板凝集和凝血机能障碍,以及胸腺、骨髓等中枢免疫器官的萎缩。CSFV还能通过引起机体抗病毒反应降低、抑制感染细胞的凋亡、促进未感染细胞的凋亡等途径造成机体免疫功能损伤。 Classical swine fever (CSF) is an acute, febrile, highly contagious infectious disease caused by classical swine fever virus (CSFV). Studies have shown that CSFV mainly infects the monocyte-macrophage system, causing severe lymphopenia, platelet aggregation and coagulation dysfunction, and atrophy of central immune organs such as thymus and bone marrow. CSFV can also cause immune function damage by reducing the body's antiviral response, inhibiting the apoptosis of infected cells, and promoting the apoptosis of uninfected cells.
程序性死亡配体(PD-L2)及其程序性死亡受体-1(PD-L2)是CD28/B7超家族成员,广泛表达于各种组织。PD-L2/PD-L共刺激信号视机体的炎症程度、免疫状态和遗传背景不同而激活或抑制,主要参与T细胞的中枢及外周免疫耐受。与其他CD28超家族成员相比,PD-L2/PD-L信号通路发挥着更广泛和复杂的免疫调节作用,与自身免疫病、肿瘤、慢性感染及炎症密切相关。在免疫调节方面,PD-L2与其配体PD-Ls共同介导PD-L2:PD-L信号通路的激活,在中枢免疫和外周免疫反应中传递免疫耐受和免疫抑制信号,对抗原特异性T、B细胞的功能、T细胞的增殖、细胞因子的分泌和杀伤能力都有抑制作用,阻断该通路后可以恢复T细胞的大部分功能。经相关研究证实,一些病毒的感染可以诱导PD-L2及其受体PD-Ls的表达,从而影响PD-L2:PD-Ls通路,使病毒逃避免疫系统的监视与杀伤,引起机体产生免疫抑制和持续性感染。因此,PD-L2及其配体PD-Ls近年来逐渐成为人们在慢性持续性病毒感染、免疫耐受性疾病、肿瘤等免疫抑制性疾病研究中所关注的热点,而在动物免疫抑制性疾病或病毒持续性感染方面,T细胞免疫抑制通路PD-L2:PD-Ls的研究才刚刚起步,特别是在猪病毒性疾病方面的研究还少见报道。 Programmed death ligand (PD-L2) and its programmed death receptor-1 (PD-L2) are members of the CD28/B7 superfamily and are widely expressed in various tissues. PD-L2/PD-L co-stimulatory signals are activated or inhibited depending on the degree of inflammation, immune status and genetic background of the body, and are mainly involved in the central and peripheral immune tolerance of T cells. Compared with other members of the CD28 superfamily, the PD-L2/PD-L signaling pathway plays a more extensive and complex role in immune regulation, and is closely related to autoimmune diseases, tumors, chronic infection and inflammation. In terms of immune regulation, PD-L2 and its ligand PD-Ls jointly mediate the activation of the PD-L2:PD-L signaling pathway, transmit immune tolerance and immunosuppressive signals in the central immune and peripheral immune responses, and are specific to antigens The function of T and B cells, the proliferation of T cells, the secretion of cytokines and the killing ability all have an inhibitory effect. After blocking this pathway, most of the functions of T cells can be restored. It has been confirmed by related studies that the infection of some viruses can induce the expression of PD-L2 and its receptor PD-Ls, thereby affecting the PD-L2:PD-Ls pathway, making the virus escape the surveillance and killing of the immune system, and causing the body to produce immunosuppression and persistent infection. Therefore, PD-L2 and its ligand PD-Ls have gradually become the focus of attention in the research of chronic persistent viral infection, immune tolerance disease, tumor and other immunosuppressive diseases in recent years. Or in terms of persistent viral infection, the research on the T cell immunosuppressive pathway PD-L2:PD-Ls has just started, especially the research on porcine viral diseases is still rarely reported.
近年来,实时荧光定量PCR(Real-TimePCR)技术为基因丰度检测提供了全新的方法,和传统的方法相比,具有敏感性高、特异性强、操作简便、成本低以及定量准确被广泛应用,它可以通过检测目标序列PCR扩增的荧光信号强度达到实时监控的目的。然而对猪外周血单核细胞中PD-L2基因的丰度的Real-TimePCR检测体系建立及应用的研究尚未见报道。 In recent years, real-time fluorescent quantitative PCR (Real-TimePCR) technology has provided a new method for gene abundance detection. Compared with traditional methods, it has high sensitivity, strong specificity, easy operation, low cost and accurate quantification. application, it can achieve the purpose of real-time monitoring by detecting the fluorescent signal intensity of PCR amplification of the target sequence. However, the establishment and application of the Real-TimePCR detection system for the abundance of PD-L2 gene in porcine peripheral blood mononuclear cells has not been reported.
发明内容 Contents of the invention
本发明要解决的技术问题在于:本发明提供了一种猪外周血单核淋巴细胞PD-L2实时荧光定量PCR阳性标准重组质粒的构建方法; The technical problem to be solved by the present invention is: the present invention provides a method for constructing a positive standard recombinant plasmid of PD-L2 real-time fluorescent quantitative PCR in porcine peripheral blood mononuclear lymphocytes;
在此基础上本发明建立了一种PD-L2基因丰度的实时荧光定量PCR检测方法,该方法具有敏感性高、特异性强等优点; On this basis, the present invention establishes a real-time fluorescence quantitative PCR detection method for PD-L2 gene abundance, which has the advantages of high sensitivity and strong specificity;
本发明通过研究外周血单核细胞中PD-L2的变化规律,为猪PD-L2分子检测的定量分析提供了技术平台,并能用于分析猪感染病毒性疾病如CSF后PD-L2基因的转录水平的变化规律中。 The invention provides a technical platform for the quantitative analysis of porcine PD-L2 molecular detection by studying the change rule of PD-L2 in peripheral blood mononuclear cells, and can be used to analyze the expression of PD-L2 gene after porcine infection with viral diseases such as CSF Changes in transcription levels.
本发明的技术方案:Technical scheme of the present invention:
猪外周血单核淋巴细胞PD-L2实时荧光定量PCR阳性标准重组质粒的构建方法,包括以下步骤: A method for constructing a positive standard recombinant plasmid for PD-L2 real-time fluorescent quantitative PCR of porcine peripheral blood mononuclear lymphocytes, comprising the following steps:
采集仔猪的外周血,分离出外周血单核淋巴细胞,提取外周血单核淋巴细胞的总RNA,将总RNA反转录成cDNA,将cDNA保存于-20℃,采用普通PCR方法扩增PD-L2目的基因片段; Collect the peripheral blood of piglets, isolate the peripheral blood mononuclear lymphocytes, extract the total RNA of the peripheral blood mononuclear lymphocytes, reverse transcribe the total RNA into cDNA, store the cDNA at -20°C, and amplify PD by common PCR method - L2 target gene fragment;
采用普通PCR方法扩增PD-L2目的基因片段,将该目的基因片段经琼脂糖凝胶电泳检测,并回收纯化;然后将PD-L2目的基因纯化片段与pMD18-T载体连接,转化至感受态细胞DH5α中,提取重组质粒,经克隆筛选后进行测序分析,得到与目的基因片段相同序列的阳性标准重组质粒; Amplify the PD-L2 target gene fragment by common PCR method, detect the target gene fragment by agarose gel electrophoresis, recover and purify; then connect the purified PD-L2 target gene fragment with the pMD18-T vector, and transform it into a competent state Extract the recombinant plasmid from DH5α cells, perform sequencing analysis after cloning and screening, and obtain a positive standard recombinant plasmid with the same sequence as the target gene fragment;
其中普通PCR扩增时的反应体系为25μL,反应体系如下:2μL样品cDNA模板,2.5μL10×PCRBuffer,2μLdNTP,浓度均为20μmol/L的正向引物和反向引物各0.5μL,0.5μL的TaqDNA聚合酶,其余为无菌三蒸水;普通PCR反应程序:95℃热启动1min;94℃变性30s;55℃退火30s;72℃延伸30s,30个循环,最后72℃延伸10min; The reaction system for ordinary PCR amplification is 25 μL, and the reaction system is as follows: 2 μL sample cDNA template, 2.5 μL 10×PCRBuffer, 2 μL dNTP, 0.5 μL each of the forward primer and reverse primer at a concentration of 20 μmol/L, and 0.5 μL of TaqDNA Polymerase, the rest is sterile triple-distilled water; common PCR reaction procedure: hot start at 95°C for 1min; denaturation at 94°C for 30s; annealing at 55°C for 30s; extension at 72°C for 30s, 30 cycles, and finally extension at 72°C for 10 minutes;
其中,正向引物F为:5′-GCCAACACCAGCTATACCAAGAC-3′ Among them, the forward primer F is: 5'-GCCAACACCAGCTATACCAAGAC-3'
反向引物R为:5′-GGGATGAAAACACGGAGCA-3′。 The reverse primer R is: 5'-GGGATGAAAACACGGAGCA-3'.
所述目的基因片段为SEQIDNo.1;所述普通PCR扩增时的反应程序:95℃热启动1min;94℃变性30s;55℃退火30s;72℃延伸30s,30个循环,最后72℃延伸10min。 The target gene fragment is SEQIDNo.1; the reaction procedure for ordinary PCR amplification: hot start at 95°C for 1min; denaturation at 94°C for 30s; annealing at 55°C for 30s; extension at 72°C for 30s, 30 cycles, and finally extension at 72°C 10min.
一种猪外周血单核淋巴细胞PD-L2基因的丰度实时检测方法,包括以下步骤: A method for real-time detection of the abundance of PD-L2 gene in porcine peripheral blood mononuclear lymphocytes, comprising the following steps:
(1)将回收纯化的PD-L2目的基因片段与pMD18-T载体连接,然后转化至感受态细胞DH5α中,提取重组质粒;经克隆筛选后进行测序分析,选取与PD-L2目的基因片段相同序列的阳性质粒作为标准品质粒,测定标准品质粒的DNA浓度,并换算成质粒的拷贝浓度,按1:10倍的浓度梯度稀释阳性质粒; (1) Ligate the recovered and purified PD-L2 target gene fragment with the pMD18-T vector, then transform it into competent cells DH5α, and extract the recombinant plasmid; perform sequencing analysis after clone screening, and select the same PD-L2 target gene fragment The positive plasmid of the sequence is used as the standard plasmid, the DNA concentration of the standard plasmid is measured, and converted into the copy concentration of the plasmid, and the positive plasmid is diluted in a concentration gradient of 1:10 times;
(2)以稀释的阳性质粒为模板,进行实时荧光定量PCR扩增反应,用实时荧光定量PCR仪检测荧光信号,反应结束后绘制出标准曲线,然后根据荧光信号的变化及标准曲线测出样品DNA中PD-L2的基因丰度; (2) Use the diluted positive plasmid as a template to carry out real-time fluorescent quantitative PCR amplification reaction, detect the fluorescent signal with a real-time fluorescent quantitative PCR instrument, draw a standard curve after the reaction, and then measure the sample according to the change of the fluorescent signal and the standard curve Gene abundance of PD-L2 in DNA;
其中实时荧光定量PCR扩增的反应体系为20μL,包括2μL质粒模板,浓度为20μmol/L的正向引物F和反向引物R各0.2μL,SYBRGreenIPreMix10μL,三蒸水7.6μL; The reaction system for real-time fluorescence quantitative PCR amplification is 20 μL, including 2 μL plasmid template, 0.2 μL each of forward primer F and reverse primer R at a concentration of 20 μmol/L, 10 μL of SYBRGreenIPreMix, and 7.6 μL of triple-distilled water;
其中,正向引物F为:5′-GCCAACACCAGCTATACCAAGAC-3′; Wherein, the forward primer F is: 5'-GCCAACACCAGCTATACCAAGAC-3';
反向引物R为:5′-GGGATGAAAACACGGAGCA-3′。 The reverse primer R is: 5'-GGGATGAAAACACGGAGCA-3'.
所述目的基因片段为SEQIDNo.1;所述荧光定量PCR扩增的反应程序为:95℃热启动30s;94℃变性5s;60℃退火和延伸34s,60℃时收集荧光信号,再40个循环。 The target gene fragment is SEQIDNo.1; the reaction program of the fluorescent quantitative PCR amplification is: 95°C hot start for 30s; 94°C denaturation for 5s; cycle.
所述稀释的阳性质粒浓度范围为为2.66×1010-2.66×101copies/μL;所述标准曲线为Y=-3.334X+22.87。 The concentration range of the diluted positive plasmid is 2.66×10 10 -2.66×10 1 copies/μL; the standard curve is Y=-3.334X+22.87.
所述的猪外周血单核淋巴细胞PD-L2基因的丰度实时检测方法在分析猪感染病毒性疾病后PD-L2基因的转录水平变化规律中的应用。 The application of the real-time detection method for the abundance of PD-L2 gene in porcine peripheral blood mononuclear lymphocytes is used in the analysis of the variation law of the transcription level of PD-L2 gene after pigs are infected with viral diseases.
本发明的积极有益效果:Positive beneficial effect of the present invention:
本发明通过合成正向引物、反向引物和PD-L2目的基因片段,建立了猪外周血单核细胞中PD-L2基因丰度的实时荧光定量PCR的方法,为更好的对猪病毒性疾病中PD-L2的转录水平进行准确定量,进而研究外周血单核细胞中PD-L2的变化规律,为猪PD-L2分子检测的定量分析提供了技术平台,并为PD-L2在猪病毒性疾病中发挥的生物学功能及其应用机制奠定基础。 The present invention establishes a real-time fluorescence quantitative PCR method for PD-L2 gene abundance in porcine peripheral blood mononuclear cells by synthesizing forward primers, reverse primers, and PD-L2 target gene fragments, in order to better detect porcine viral Accurately quantify the transcription level of PD-L2 in the disease, and then study the change rule of PD-L2 in peripheral blood mononuclear cells, provide a technical platform for the quantitative analysis of porcine PD-L2 molecular detection, and provide a basis for PD-L2 in porcine virus It lays the foundation for the biological functions and mechanisms of their application in diseases.
本发明所公开的技术方案与传统技术相比,敏感性较高,利用所建立的方法对109~101copies/μL的9组不同浓度标准阳性质粒进行检测,结果显示:本发明中PD-L2的检测下限为10copies/μL,其浓度与Ct值之间有较好的线性关系,相关系数R2=0.998;利用建立的方法进行重复性试验,组内和组间重复性试验结果表明,变异系数均在3%以内,具有较好的重复性;从溶解曲线图可知,PD-L2分子溶解曲线出现单一狭窄峰(图4),且琼脂糖凝胶电泳分析表明,Real-timeRT-PCR扩增结果为单一特异性目的片段(图5),说明本发明具有较好的特异性;另外本技术方案还具有检测通量高、操作简便、成本低以及定量准确等特点。 Compared with the traditional technology, the technical solution disclosed in the present invention has higher sensitivity. Using the established method to detect 9 groups of standard positive plasmids with different concentrations of 10 9 to 10 1 copies/μL, the results show that: PD in the present invention The lower detection limit of -L2 is 10copies/μL, and there is a good linear relationship between its concentration and C t value, the correlation coefficient R 2 =0.998; the repeatability test was carried out using the established method, and the repeatability test results within and between groups It shows that the coefficients of variation are all within 3%, with good repeatability; from the dissolution curve, it can be seen that a single narrow peak appears in the dissolution curve of PD-L2 molecule (Figure 4), and agarose gel electrophoresis analysis shows that Real-timeRT -The result of PCR amplification is a single specific target fragment (Figure 5), indicating that the present invention has good specificity; in addition, the technical solution has the characteristics of high detection throughput, simple operation, low cost and accurate quantification.
本发明通过实验证实,猪感染CSFV后,随着病毒在机体内复制PD-L2的表达量逐渐升高,说明CSFV的感染及病毒载量与猪PD-L2基因丰度的变化关系十分密切;并证实了猪感染CSFV后PD-L2表达变化与IL-2和IL-10细胞因子的表达变化之间存在一定关系,猪PD-L2表达升高后激活了PD-L2:PD-Ls信号通路,引起了猪T细胞免疫功能下降,导致感染猪免疫功能降低。 The present invention proves through experiments that after pigs are infected with CSFV, the expression level of PD-L2 gradually increases as the virus replicates in the body, indicating that the infection of CSFV and the viral load are closely related to the change of pig PD-L2 gene abundance; It was also confirmed that there is a certain relationship between the expression changes of PD-L2 and the expression changes of IL-2 and IL-10 cytokines after pigs infected with CSFV. , causing a decrease in the immune function of pig T cells, resulting in a decrease in the immune function of infected pigs.
本发明的猪PD-L2基因实时荧光定量PCR检测方法,为检测猪病毒性疾病如CSF(猪瘟)所导致的免疫功能损伤中PD-L2的表达变化规律提供了技术平台,从而进一步丰富了猪瘟引起免疫功能损伤的机理。 The porcine PD-L2 gene real-time fluorescent quantitative PCR detection method of the present invention provides a technical platform for detecting the expression change law of PD-L2 in immune function damage caused by porcine viral diseases such as CSF (swine fever), thereby further enriching The mechanism of immune function damage caused by classical swine fever.
附图说明 Description of drawings
图1为琼脂糖凝胶检测猪PD-L2基因扩增结果; Figure 1 is the result of agarose gel detection of porcine PD-L2 gene amplification;
图2为猪PD-L2实时荧光定量分析扩增曲线; Figure 2 is the amplification curve of real-time fluorescence quantitative analysis of porcine PD-L2;
图3为猪PD-L2实时荧光定量分析标准曲线; Figure 3 is the standard curve for real-time fluorescence quantitative analysis of porcine PD-L2;
图4为猪PD-L2实时荧光定量分析标准品溶解曲线; Figure 4 is the dissolution curve of the standard substance for real-time fluorescence quantitative analysis of porcine PD-L2;
图5为猪PD-L2实时荧光定量产物特异性分析结果; Figure 5 shows the results of real-time fluorescent quantitative product specificity analysis of porcine PD-L2;
图6为猪感染CSFV不同时期外周血单核细胞中PD-L2基因的拷贝数; Figure 6 is the copy number of PD-L2 gene in the peripheral blood mononuclear cells of pigs infected with CSFV at different stages;
图7为猪感染CSFV不同时期血浆中CSFV病毒载量检测结果; Fig. 7 is the detection result of CSFV viral load in the blood plasma of different periods of pig infection CSFV;
图8为猪感染CSFV不同时期IL-2基因的拷贝数; Fig. 8 is the copy number of IL-2 gene in different stages of pig infection CSFV;
图9为猪感染CSFV不同时期IL-10基因的拷贝数。 Fig. 9 is the copy number of IL-10 gene in pigs infected with CSFV at different stages.
具体实施方式 detailed description
在本发明中,基因拷贝数、基因丰度代表同样的概念;Real-timePCR、实时荧光定量PCR表示同样的概念;ddH2O表示双蒸水;CSF表示猪瘟;CSFV表示猪瘟病毒,羧基荧光素二醋酸盐琥珀酰亚胺酯(carboxyfluoresceinsuccinimidylaminoester,CFSE)为一种可以标记活体细胞的荧光染料。 In the present invention, gene copy number and gene abundance represent the same concept; Real-timePCR and real-time fluorescent quantitative PCR represent the same concept; ddH 2 O represents double distilled water; CSF represents swine fever; CSFV represents swine fever virus, carboxyl Fluorescein diacetate succinimidyl ester (carboxyfluoresceinsuccinimidylaminoester, CFSE) is a fluorescent dye that can label living cells.
实施例中的实验动物和菌种:30日龄健康仔猪,隔离器中饲养;石门株CSFV由中国兽医药品检查所提供,半数感染量为105×TCID50;大肠杆菌感受态细胞DH5α,为本实验室保存。 Experimental animals and bacterial strains in the examples: 30-day-old healthy piglets were raised in isolators; Shimen strain CSFV was provided by the China Veterinary Drug Inspection Institute, and the half infection rate was 10 5 ×TCID 50 ; Escherichia coli competent cells DH5α were Saved by this laboratory.
主要试剂和仪器:淋巴细胞分离液,购自天津灏阳生物制品科技有限公司;PCR产物纯化回收试剂盒,购自上海生工生物工程技术服务有限公司;TaqDNA聚合酶、反转录试剂盒、pMD18-T载体,均购自大连宝生物工程有限公司;SYBRGreenI,购自Invitrogen公司。 Main reagents and instruments: lymphocyte separation medium, purchased from Tianjin Haoyang Biological Products Technology Co., Ltd.; PCR product purification and recovery kit, purchased from Shanghai Sangon Bioengineering Technology Service Co., Ltd.; TaqDNA polymerase, reverse transcription kit, The pMD18-T vector was purchased from Dalian Bao Biological Engineering Co., Ltd.; SYBRGreenI was purchased from Invitrogen.
实施例1猪PD-L2实时荧光定量PCR阳性标准重组质粒的构建 Example 1 Construction of porcine PD-L2 real-time fluorescence quantitative PCR positive standard recombinant plasmid
采集45日龄仔猪的外周血,参照淋巴细胞分离液的说明书分离外周血的淋巴细胞,参照Invitrogen公司TRIzol试剂盒说明书和相关文献进行总RNA的提取。提取的总RNA参照反转录试剂盒说明书反转录成cDNA,保存于-20℃备用,用于扩增PD-L2目的基因片段的模板。 The peripheral blood of 45-day-old piglets was collected, and the lymphocytes in the peripheral blood were separated according to the instructions of the lymphocyte separation medium, and the total RNA was extracted according to the instructions of the Invitrogen TRIzol kit and related literature. The extracted total RNA was reverse-transcribed into cDNA according to the instructions of the reverse transcription kit, and stored at -20°C for use as a template for amplifying the PD-L2 target gene fragment.
采用普通PCR方法扩增PD-L2目的基因片段,将该目的基因片段经琼脂糖凝胶电泳检测,并回收纯化;然后将PD-L2目的基因纯化片段与pMD18-T载体连接,转化至感受态细胞DH5α中,提取重组质粒,经克隆筛选后进行测序分析,得到与目的基因片段相同序列的阳性标准重组质粒; Amplify the PD-L2 target gene fragment by common PCR method, detect the target gene fragment by agarose gel electrophoresis, recover and purify; then connect the purified PD-L2 target gene fragment with the pMD18-T vector, and transform it into a competent state Extract the recombinant plasmid from DH5α cells, perform sequencing analysis after cloning and screening, and obtain a positive standard recombinant plasmid with the same sequence as the target gene fragment;
所述目的基因片段为序列SEQIDNo.1: The target gene fragment is the sequence SEQIDNo.1:
GCCAACACCAGCTATACCAAGACATCTGAAGGCCTCTACCAGGTCACTAGTGTTCTGCGCCTAAAGCCACACCCTGGTAGAAATTTCAGCTGTGTGTTCTGGAATGCCAACATGAAGGAATTTACTTTAGTCATCATCGTCCCAGGTGATATGGAAACCCACAAGACCCCTGCATCTTCACTGCTCCGTGTTTTCATCCC。 GCCAACACCAGCTATACCAAGACATCTGAAGGCCTCTACCAGGTCACTAGTGTTCTGCGCCTAAAGCCACACCCTGGTAGAAATTTCAGCTGTGTGTTCTGGAATGCCAACATGAAGGAATTTACTTTAGTCATCATCGTCCCAGGTGATATGGAAACCCACAAGACCCCTGCATCTTCACTGCTCCGTGTTTTCATCCC.
用以构建PD-L2实时荧光定量PCR阳性标准重组质粒的普通PCR反应体系: Common PCR reaction system for constructing PD-L2 real-time fluorescent quantitative PCR positive standard recombinant plasmid:
普通PCR反应体系为25μL,反应体系如下:2μL样品DNA模板,阴性对照以无菌三蒸水为模板,2.5μL10×PCRBuffer,2μLdNTP,正、反向引物各0.5μL(20μmol/L),0.5μLTaqDNA聚合酶(大连宝生物工程公司),其余体积以无菌三蒸水补足;将反应体系轻柔混合,于普通PCR仪进行扩增反应。 The general PCR reaction system is 25 μL, and the reaction system is as follows: 2 μL sample DNA template, negative control with sterile three-distilled water as template, 2.5 μL 10×PCRBuffer, 2 μL dNTP, 0.5 μL each of forward and reverse primers (20 μmol/L), 0.5 μL TaqDNA Polymerase (Dalian Bao Biological Engineering Co., Ltd.), and the remaining volume was made up with sterile three-distilled water; the reaction system was gently mixed, and the amplification reaction was carried out in an ordinary PCR machine.
普通PCR程序为:95℃热启动1min;94℃变性30s;55℃退火30s;72℃延伸30s,30个循环,最后72℃延伸10min。 The general PCR program is: hot start at 95°C for 1 min; denaturation at 94°C for 30 s; annealing at 55°C for 30 s; extension at 72°C for 30 s, 30 cycles, and finally extension at 72°C for 10 min.
其中猪PD-L2实时荧光定量PCR引物由某生物公司合成,引物序列如下: Among them, the porcine PD-L2 real-time fluorescent quantitative PCR primers were synthesized by a biological company, and the primer sequences are as follows:
正向引物F为:5′-GCCAACACCAGCTATACCAAGAC-3′, The forward primer F is: 5′-GCCAACACCAGCTATACCAAGAC-3′,
反向引物R为:5′-GGGATGAAAACACGGAGCA-3′。 The reverse primer R is: 5'-GGGATGAAAACACGGAGCA-3'.
将普通PCR产物进行2%琼脂糖电泳分析,电压100V,35min后在紫外灯下观察产物,结果显示扩增出单一条带,片段大小在200bp左右。 The normal PCR product was subjected to 2% agarose electrophoresis analysis, the voltage was 100V, and the product was observed under the ultraviolet light after 35 minutes. The result showed that a single band was amplified, and the fragment size was about 200bp.
扩增结果见附图1,图中M为DL2000分子量标准,1为PD-L2基因的扩增产物,扩增条带较清晰,无引物二聚体影响。扩增序列经克隆、测序后,在GenBank中进行核酸同源性的比对,结果显示,获得的序列SEQIDNo.1与GenBank中猪PD-L2基因(NM_001204379)的序列同源性为100%,说明引物及扩增产物都正确,可用于下一步实验研究。将特异性片段进行琼脂糖凝胶回收后,进行克隆转化,将获得的阳性克隆交由上海生工生物工程技术服务有限公司进行测序分析。 The amplification results are shown in Figure 1. In the figure, M is the DL2000 molecular weight standard, and 1 is the amplification product of the PD-L2 gene. The amplification band is relatively clear, and there is no influence of primer-dimer. After the amplified sequence was cloned and sequenced, the nucleic acid homology comparison was carried out in GenBank. The results showed that the sequence homology of the obtained sequence SEQIDNo.1 and the porcine PD-L2 gene (NM_001204379) in GenBank was 100%. It shows that the primers and amplification products are correct and can be used in the next step of experimental research. After the specific fragments were recovered from the agarose gel, clone transformation was carried out, and the obtained positive clones were sent to Shanghai Sangon Bioengineering Technology Service Co., Ltd. for sequencing analysis.
实施例2:猪PD-L2实时荧光定量PCR体系的建立 Example 2: Establishment of porcine PD-L2 real-time fluorescent quantitative PCR system
(1)质粒DNA模板的制备 (1) Preparation of plasmid DNA template
采用普通PCR扩增方法扩增PD-L2目的基因片段,将目的基因片段经2%琼脂糖凝胶电泳检测并回收纯化,与pMD18-T载体(TaKaRa,大连)连接后转化至感受态细胞DH5α中,提取重组质粒;经克隆筛选后进行测序分析,测序结果显示与GenBank中猪PD-L2基因的序列100%同源,说明所获得序列正确,阳性质粒可用于质粒标准品的制作。使用微量核酸蛋白分光光度仪测定该标准品质粒DNA浓度为84.7μg/mL,将初始标准品质粒溶液进行1:10倍的倍比稀释。 The target gene fragment of PD-L2 was amplified by ordinary PCR amplification method, and the target gene fragment was detected by 2% agarose gel electrophoresis, recovered and purified, and then transformed into competent cells DH5α after ligation with pMD18-T vector (TaKaRa, Dalian) In , the recombinant plasmid was extracted; after clone screening, sequencing analysis was performed, and the sequencing results showed that it was 100% homologous to the sequence of the porcine PD-L2 gene in GenBank, indicating that the obtained sequence was correct, and the positive plasmid could be used for the production of plasmid standards. The standard plasmid DNA concentration was determined to be 84.7 μg/mL using a micronucleic acid protein spectrophotometer, and the initial standard plasmid solution was diluted 1:10 times.
(2)标准质粒浓度计算和PD-L2标准曲线的制作 (2) Calculation of standard plasmid concentration and creation of PD-L2 standard curve
提取经过测序验证的阳性克隆质粒,将质粒的DNA浓度换算成拷贝数。质粒拷贝数的计算方法为:拷贝数(copies/μL)=浓度(μg/μL)×6.02×1023(copies/μL)/MW(g/mol)。 Extract the plasmids of positive clones verified by sequencing, and convert the DNA concentration of the plasmids into copy numbers. The calculation method of plasmid copy number is: copy number (copies/μL)=concentration (μg/μL)×6.02×10 23 (copies/μL)/MW (g/mol).
其中MW=(克隆载体长度+目的片段长度)(bp))×660g/mol/bp。 Where MW = (cloning vector length + target fragment length) (bp)) × 660g/mol/bp.
已知:cDNA=84.7μg/mL,质粒PMD18-T序列长度为2692bp,PD-L2基因插入片段长度为200bp;单个碱基的平均摩尔质量为660g/mol,计算公式为: Known: cDNA=84.7μg/mL, plasmid PMD18-T sequence length is 2692bp, PD-L2 gene insert fragment length is 200bp; the average molar mass of a single base is 660g/mol, the calculation formula is:
分子量(MW)=(2692+200)×660=1.91×106g/mol。 Molecular weight (MW)=(2692+200)×660=1.91×10 6 g/mol.
质粒拷贝浓度:6.02×1023×(84.7×10-9)÷(1.91×106)=2.66×1010copies/μL。 Plasmid copy concentration: 6.02×10 23 ×(84.7×10 -9 ) ÷ (1.91×10 6 )=2.66×10 10 copies/μL.
将上述已知拷贝浓度的质粒溶液作为标准质粒,在进行Real-timePCR标准曲线绘制时按10倍梯度稀释(浓度范围为2.66×1010-2.66×101copies/μL)。 The above-mentioned plasmid solution with known copy concentration was used as the standard plasmid, and was diluted in a 10-fold gradient (concentration range: 2.66×10 10 -2.66×10 1 copies/μL) when drawing the Real-timePCR standard curve.
将已知拷贝数的质粒进行1:10倍梯度稀释,获得质粒标准品。 The plasmid with known copy number was serially diluted 1:10 times to obtain the plasmid standard.
以稀释好的质粒为模板,进行实时荧光定量PCR扩增反应,反应采用Real-timePCR试剂盒SYBRPremixExTaqTM(Invitrogen公司),反应体系为20μL:2μL标准质粒模板,F、R引物(20μmol/L)各0.2μL,SYBRGreenIPreMix10μL,三蒸水7.6μL。每次Real-timePCR反应中均设置阴性对照(模板为2μLddH2O),Real-timePCR程序为:95℃热启动30s;94℃变性5s;60℃退火和延伸34s,60℃时收集荧光信号,40个循环。其中的F、R引物与实施例1相同。 Using the diluted plasmid as a template, real-time fluorescence quantitative PCR amplification reaction was carried out. The reaction was carried out using Real-timePCR kit SYBRPremixExTaqTM (Invitrogen Company). The reaction system was 20 μL: 2 μL standard plasmid template, F and R primers (20 μmol/L) each 0.2 μL, SYBRGreenIPreMix 10 μL, triple distilled water 7.6 μL. A negative control (template 2 μL ddH 2 O) was set in each Real-time PCR reaction. The Real-time PCR program was: 95°C hot start for 30s; 94°C denaturation for 5s; 60°C annealing and extension for 34s; collect fluorescence signals at 60°C 40 loops. The F and R primers are the same as in Example 1.
标准曲线及所有待测样品均设置3个平行反应。反应在ABI7500定量PCR仪(美国LifeTechnologies)中进行,利用ABI7500软件检测和收集荧光信号,并进行数据分析。 Three parallel reactions were set up for the standard curve and all samples to be tested. The reaction was carried out in ABI7500 quantitative PCR instrument (LifeTechnologies, USA), and ABI7500 software was used to detect and collect fluorescent signals, and perform data analysis.
ABI7500软件实时荧光定量分析软件自行绘制出反应的扩增曲线(见附图2)。扩增曲线显示从左至右6条曲线依次代表标准品107、106、105、104、103、102的梯度稀释液的扩增曲线,6个质粒标准品扩增曲线较光滑,呈现典型的S型,且各循环阈值(Ct值)间隔均匀。 The real-time fluorescence quantitative analysis software of ABI7500 software draws the amplification curve of the reaction by itself (see Figure 2). The amplification curve shows that the six curves from left to right represent the amplification curves of the gradient dilutions of standard products 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , and 10 2 . Smooth, showing a typical S-type, and each cycle threshold (Ct value) is evenly spaced.
根据扩增曲线提供的标准品各浓度梯度及反应的循环阈值(Ct值),ABI7500软件自行绘制出反应的标准曲线(见附图3)。该标准曲线的相关系数R2=0.998,斜率为-3.334,标准曲线为Y=-3.334X+22.87,其中Y为实时荧光定量PCR反应的Ct值,X为PD-L2基因构建的标准质粒拷贝数对数值。计算其扩增效率Eff%=100.618%,符合ABI7500荧光定量分析对标准曲线的要求。 According to the concentration gradient of the standard provided by the amplification curve and the cycle threshold (Ct value) of the reaction, the ABI7500 software draws the standard curve of the reaction by itself (see Figure 3). The correlation coefficient of the standard curve R 2 =0.998, the slope is -3.334, the standard curve is Y=-3.334X+22.87, where Y is the Ct value of the real-time fluorescent quantitative PCR reaction, and X is the standard plasmid copy constructed by the PD-L2 gene logarithmic value. The calculated amplification efficiency Eff%=100.618%, which meets the requirements of ABI7500 fluorescence quantitative analysis for the standard curve.
测定各浓度稀释梯度的标准品在实时荧光定量PCR过程中的溶解温度,并绘制溶解曲线(见附图4)。标准品及样品的溶解曲线型峰单一,且标准品溶解温度相同(74.5±0.5℃),表明扩增反应产物溶解温度均一,特异性好,且无引物二聚体。 Measure the melting temperature of the standard substance of each concentration dilution gradient during the real-time fluorescent quantitative PCR process, and draw the melting curve (see Figure 4). The melting curve peaks of the standard and samples were single, and the melting temperature of the standard was the same (74.5±0.5°C), indicating that the amplification reaction product had a uniform melting temperature, good specificity, and no primer-dimer.
根据荧光信号的变化及标准曲线即可测出样品DNA中PD-L2的基因丰度。 According to the change of fluorescence signal and the standard curve, the gene abundance of PD-L2 in the sample DNA can be measured.
实施例3:猪PD-L2实时荧光定量PCR体系的敏感性、特异性及重复性分析 Example 3 : Sensitivity, specificity and repeatability analysis of porcine PD-L2 real-time fluorescent quantitative PCR system
采用实施例1所构建的猪PD-L2重组质粒作为阳性重组标准质粒;采用实施例2所建立的猪PD-L2实时荧光定量PCR检测体系;实时荧光定量PCR仪采用LifeTechnologies公司(美国)生产的ABI7500荧光定量PCR仪进行。 The porcine PD-L2 recombinant plasmid constructed in Example 1 was used as the positive recombinant standard plasmid; the porcine PD-L2 real-time fluorescent quantitative PCR detection system established in Example 2 was used; the real-time fluorescent quantitative PCR instrument was produced by LifeTechnologies (USA) ABI7500 fluorescent quantitative PCR instrument was used.
用10倍系列稀释的101~109copies/μL猪PD-L2阳性重组标准质粒做敏感性试验,结果表明,PD-L2的检测下限为10copies/μL。 A 10-fold serial dilution of 10 1 to 10 9 copies/μL porcine PD-L2 positive recombinant standard plasmid was used for a sensitivity test. The results showed that the detection limit of PD-L2 was 10 copies/μL.
对猪PD-L2分子Real-time-PCR溶解曲线(见附图4)及产物琼脂糖凝胶电泳做特异性分析,结果表明,溶解曲线出现单一狭窄峰,能够扩增到与预期目的片段同样大小的特异性片段,没有生成非特异性产物和引物二聚体(见附图5)。 The specificity analysis of the real-time-PCR melting curve of porcine PD-L2 molecule (see Figure 4) and agarose gel electrophoresis of the product showed that the melting curve had a single narrow peak, which could be amplified to the same extent as the expected target fragment. The size of the specific fragment, no non-specific products and primer dimers (see Figure 5).
用建立的方法分别进行批内和批间重复性检测,结果显示,批内和批间的变异系数小于3%,重复性良好(见表1)。 The intra-assay and inter-assay repeatability tests were carried out with the established method, and the results showed that the intra-assay and inter-assay coefficients of variation were less than 3%, and the repeatability was good (see Table 1).
表1猪PD-L2实时荧光定量PCR方法批内与批间重复性评价结果 Table 1 Intra-assay and inter-assay reproducibility evaluation results of porcine PD-L2 real-time fluorescent quantitative PCR method
实施例4:利用本发明建立的实时荧光定量PCR方法,分析猪在病毒性疾病感染后外周血单核淋巴细胞中PD-L2基因丰度的变化规律。 Example 4 : Using the real-time fluorescence quantitative PCR method established by the present invention, the variation law of the PD-L2 gene abundance in peripheral blood mononuclear lymphocytes of pigs after viral disease infection was analyzed.
采用实施例2建立的猪PD-L2实时荧光定量PCR体系;实时荧光定量PCR仪采用LifeTechnologies公司(美国)生产的ABI7500荧光定量PCR仪。 The porcine PD-L2 real-time fluorescent quantitative PCR system established in Example 2 was used; the real-time fluorescent quantitative PCR instrument was ABI7500 fluorescent quantitative PCR instrument produced by Life Technologies (USA).
将15头30日龄的健康仔猪饲养至45日龄,用IDEXX猪瘟病毒抗体检测试剂盒检测,确定CSFV抗体为阴性,随机分为对照组(5头)和实验组(10头)。实验组和对照组隔离饲养,其中实验组通过颈部肌肉注射CSFV稀释液0.1mL/头;对照组用灭菌PBS作相同处理。 Fifteen 30-day-old healthy piglets were raised to 45-day-old, tested with IDEXX swine fever virus antibody detection kit, and confirmed that the CSFV antibody was negative, and were randomly divided into a control group (5 piglets) and an experimental group (10 piglets). The experimental group and the control group were kept in isolation, and the experimental group was injected with 0.1 mL/head of CSFV dilution through the neck muscle; the control group was treated with sterilized PBS for the same treatment.
分别于CSFV感染45日龄仔猪后的第0、3、7、10、14和2天采外周静脉血,并以未感染CSFV的同日龄仔猪为对照,同时分离感染组与对照组外周血单核淋巴细胞,并提取总RNA,利用反转录试剂盒(大连宝生物)反转录合成cDNA,利用实施例1提供的特异性引物,采用实施例2建立的实时荧光定量PCR体系进行检测,根据标准曲线计算即可获得感染组和对照组外周血单核淋巴细胞中PD-L2基因拷贝数(即基因丰度),见附图6。 Peripheral venous blood was collected on days 0, 3, 7, 10, 14, and 2 after CSFV infection of 45-day-old piglets, and piglets of the same age that were not infected with CSFV were used as controls. Nuclear lymphocytes, and total RNA was extracted, and cDNA was synthesized by reverse transcription using a reverse transcription kit (Dalian Bao Biology), using the specific primers provided in Example 1, and using the real-time fluorescent quantitative PCR system established in Example 2 for detection. The PD-L2 gene copy number (ie, gene abundance) in the peripheral blood mononuclear lymphocytes of the infection group and the control group can be obtained by calculating according to the standard curve, as shown in Figure 6.
结果显示,与未感染CSFV健康仔猪相比,在CSFV感染后的不同时期,因为机体的免疫状态不同,各期PD-L2基因的丰度不同,在感染后第3~10天与对照组相比显著(P<0.05)升高,其中第3天升高显著(P<0.05);第7天持续升高,与对照组相比极显著(P<0.01),第10天开始下降,但与对照组相比仍显著(P<0.05),之后继续降低,且没有统计学意义。由此可见,猪PD-L2基因的丰度和猪瘟病程具有较大的关联。 The results showed that compared with healthy piglets not infected with CSFV, the abundance of PD-L2 gene was different at different stages after CSFV infection due to the different immune status of the body. Compared with the control group (P<0.05), it increased significantly (P<0.05) on the 3rd day; continued to increase on the 7th day, which was extremely significant compared with the control group (P<0.01), and began to decrease on the 10th day, but Compared with the control group, it was still significant (P<0.05), and then continued to decrease without statistical significance. It can be seen that the abundance of porcine PD-L2 gene has a greater correlation with the course of classical swine fever.
实施例5:猪瘟病毒(CSFV)感染猪后PD-L2表达变化与血浆中病毒载量之间的关系 Example 5: The relationship between the change of PD-L2 expression and the viral load in plasma after swine fever virus (CSFV) infection
CSFV载量实时荧光定量PCR引物及探针由某生物公司合成,引物及探针序列如下: Primers and probes for real-time fluorescent quantitative PCR of CSFV load were synthesized by a biological company. The sequences of primers and probes are as follows:
正向引物F:5’-CCCTGAAGTGGATTAGAA-3’, Forward primer F: 5'-CCCTGAAGTGGATTAGAA-3',
反向引物R:5’-TACCCTTGTTGATCCTATC-3’, Reverse primer R: 5'-TACCCTTGTTGATCCTATC-3',
TaqManprobe:5’-(FAM)TTCACCGACTGTCCATTGTGG(Eclipse)-3’ TaqManprobe: 5'-(FAM)TTCACCGACTGTCCATTGTGG(Eclipse)-3'
分别于CSFV感染45日龄仔猪后的第0、3、7、10、14和21天采取外周血,提取外周血中CSFV的总RNA,利用反转录试剂盒(大连宝生物)反转录合成cDNA。反转录反应体系为:2μL5×PrimeScriptBuffer,0.5μLPrimeScriptRTEnzymeMixI,0.5μLOligodT引物,0.5μLRandom6mers,1μg总RNA和RNaseFreedH2O。反转录反应条件为:37℃反应15分钟,85℃5秒,合成cDNA置于-20℃保存备用。实时荧光定量PCR检测CSFV的载量,试剂为premixExTaq(probeqPCR)(大连宝生物),在ABI7500仪器进行,实时荧光定量PCR反应体系为20μL体系:10μLPremixExTaq,0.4μLCSFV正向引物(10μmol/L),0.4μL反向引物(10μmol/L),0.8μLTaqMan探针(10μmol/L),0.4μLROXPreferenceDye,2μL模板DNA和6μL三蒸水。反应体系为:95℃热启动10秒,45个循环,95℃变性15秒,56℃退火和延伸45秒。根据标准曲线计算血浆中CSFV的载量。 The peripheral blood was collected on the 0, 3, 7, 10, 14 and 21 days after CSFV infection of 45-day-old piglets, and the total RNA of CSFV in the peripheral blood was extracted, and the reverse transcription kit (Dalian Baobio) was used to reverse transcribe Synthesize cDNA. The reverse transcription reaction system was: 2 μL 5×PrimeScriptBuffer, 0.5 μL PrimeScriptRTEnzymeMixI, 0.5 μL LigodT primer, 0.5 μL Random6mers, 1 μg total RNA and RNaseFreedH2O. The reverse transcription reaction conditions were: 37°C for 15 minutes, 85°C for 5 seconds, and the synthesized cDNA was stored at -20°C for future use. Real-time fluorescent quantitative PCR was used to detect the load of CSFV, the reagent was premixExTaq (probeqPCR) (Dalian Bao Biology), and it was carried out on ABI7500 instrument. The real-time fluorescent quantitative PCR reaction system was 20 μL system: 10 μL PremixExTaq, 0.4 μL CSFV forward primer (10 μmol/L), 0.4 μL reverse primer (10 μmol/L), 0.8 μL TaqMan probe (10 μmol/L), 0.4 μL ROXPreferenceDye, 2 μL template DNA and 6 μL triple distilled water. The reaction system was: hot start at 95°C for 10 seconds, 45 cycles, denaturation at 95°C for 15 seconds, annealing and extension at 56°C for 45 seconds. The load of CSFV in plasma was calculated according to the standard curve.
结果表明,在CSFV感染后第3天病毒载量开始升高,第7天达到峰值,之后逐渐降低(见附图7)。 The results showed that the viral load began to increase on the 3rd day after CSFV infection, reached a peak on the 7th day, and then gradually decreased (see Figure 7).
结合实施例4结果可以看出,随着病毒在机体内的复制,PD-L2的表达量逐渐升高,说明CSFV的感染及病毒载量与猪PD-L2基因丰度的变化关系十分密切。 Combining the results of Example 4, it can be seen that with the replication of the virus in the body, the expression level of PD-L2 gradually increases, indicating that the infection of CSFV and the viral load are closely related to the changes in the abundance of the porcine PD-L2 gene.
实施例6:猪CSFV感染后PD-L2表达变化与IL-2、IL-10细胞因子表达变化之间的关系 Example 6: Relationship between PD-L2 expression changes and IL-2, IL-10 cytokine expression changes after porcine CSFV infection
采用实施例2建立的猪PD-L2实时荧光定量PCR体系,采用实施例4的CSFV感染45日龄仔猪后第0、3、7、10、14和21天的外周血,以其外周血单核淋巴细胞的总RNA反转录cDNA的产物为模板,对CSFV感染后第第0、3、7、10、14和21天的猪细胞因子IL-2、IL-10的表达变化进行检测。 Using the porcine PD-L2 real-time fluorescent quantitative PCR system established in Example 2, adopting the peripheral blood of 0, 3, 7, 10, 14 and 21 days after the CSFV infection of Example 4 of 45-day-old piglets, and using its peripheral blood list The total RNA of nuclear lymphocytes was reverse-transcribed into cDNA as a template, and the expression changes of porcine cytokines IL-2 and IL-10 were detected on days 0, 3, 7, 10, 14 and 21 after CSFV infection.
实时荧光定量PCR仪采用LifeTechnologies公司(美国)生产的ABI7500荧光定量PCR仪进行。 The real-time fluorescent quantitative PCR instrument was carried out by ABI7500 fluorescent quantitative PCR instrument produced by Life Technologies (USA).
结果表明,IL-2mRNA表达水平在CSFV感染第7天表达水平降低(P<0.05),当PD-L2表达增高时(第7天),IL-10表达水平升高且变化极显著(P<0.01),见附图8。 The results showed that the expression level of IL-2 mRNA decreased on the 7th day of CSFV infection (P<0.05), and when the expression of PD-L2 increased (7th day), the expression level of IL-10 increased and the change was extremely significant (P<0.05). 0.01), see Figure 8.
CSFV感染后,PD-L2表达量升高,激活PD-L2:PD-Ls信号通路,导致IL-2表达的降低(第7天),见附图9。于此同时,IL-10的表达量升高(第7天),说明在CSFV感染后,IL-10的表达影响了PD-L2的表达。而IL-10是一种免疫抑制性细胞因子,所以CSFV感染后,猪PD-L2表达的升高,激活了PD-L2:PD-Ls信号通路,以及IL-2的降低和IL-10的升高,使机体处在免疫抑制的状态。 After CSFV infection, the expression of PD-L2 increased, activating the PD-L2:PD-Ls signaling pathway, resulting in a decrease in IL-2 expression (day 7), see Figure 9. At the same time, the expression of IL-10 increased (day 7), indicating that the expression of IL-10 affected the expression of PD-L2 after CSFV infection. IL-10 is an immunosuppressive cytokine, so after CSFV infection, the expression of PD-L2 in pigs increased, which activated the PD-L2:PD-Ls signaling pathway, and the reduction of IL-2 and the expression of IL-10 Elevated, so that the body is in a state of immunosuppression.
SEQUENCELISTING SEQUENCELISTING
<110>新乡学院 <110> Xinxiang College
<120>猪外周血单核淋巴细胞PD-L2重组质粒的构建、基因丰度实时检测方法及其 <120> Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its
应用 application
<130>分子病理学与免疫学研究 <130> Molecular Pathology and Immunology Research
<160>6 <160>6
<170>PatentInversion3.4 <170>PatentInversion3.4
<210>1 <210>1
<211>200 <211>200
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>1 <400>1
gccaacaccagctataccaagacatctgaaggcctctaccaggtcactagtgttctgcgc60 gccaacaccagctataccaagacatctgaaggcctctaccaggtcactagtgttctgcgc60
ctaaagccacaccctggtagaaatttcagctgtgtgttctggaatgccaacatgaaggaa120 ctaaagccacaccctggtagaaatttcagctgtgtgttctggaatgccaacatgaaggaa120
tttactttagtcatcatcgtcccaggtgatatggaaacccacaagacccctgcatcttca180 tttactttagtcatcatcgtcccaggtgatatggaaacccacaagacccctgcatcttca180
ctgctccgtgttttcatccc200 ctgctccgtgttttcatccc200
<210>2 <210>2
<211>23 <211>23
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>2 <400>2
gccaacaccagctataccaagac23 gccaacaccagctataccaagac23
<210>3 <210>3
<211>19 <211>19
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>3 <400>3
gggatgaaaacacggagca19 gggatgaaaacacggagca19
<210>4 <210>4
<211>18 <211>18
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>4 <400>4
ccctgaagtggattagaa18 ccctgaagtggattagaa18
<210>5 <210>5
<211>19 <211>19
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>5 <400>5
tacccttgttgatcctatc19 tacccttgttgatcctatc19
<210>6 <210>6
<211>21 <211>21
<212>DNA <212>DNA
<213>人工序列 <213> Artificial sequence
<400>6 <400>6
ttcaccgactgtccattgtgg21 ttcaccgactgtccattgtgg21
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410102233.2A CN103966312B (en) | 2014-03-19 | 2014-03-19 | Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410102233.2A CN103966312B (en) | 2014-03-19 | 2014-03-19 | Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103966312A CN103966312A (en) | 2014-08-06 |
| CN103966312B true CN103966312B (en) | 2016-01-13 |
Family
ID=51236314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410102233.2A Active CN103966312B (en) | 2014-03-19 | 2014-03-19 | Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103966312B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007067681A2 (en) * | 2005-12-08 | 2007-06-14 | University Of Louisville Research Foundation, Inc. | Immunostimulatory compositions and methods |
-
2014
- 2014-03-19 CN CN201410102233.2A patent/CN103966312B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007067681A2 (en) * | 2005-12-08 | 2007-06-14 | University Of Louisville Research Foundation, Inc. | Immunostimulatory compositions and methods |
Non-Patent Citations (2)
| Title |
|---|
| PD-1 y sus ligandos como reguladores de la respuesta inmune;MARÍA INÉS VARGAS-ROJAS;《REV INST NAL ENF RESP MEX》;20081231;第21卷(第4期);272-279 * |
| 猪PD-1分子及其配体的实时荧光定量RT-PCR检测方法的建立;彭金美;《中国兽医科学》;20100420;第40卷(第4期);参见摘要、第411-412页第1节、第412页第2节、图1及第413页第3节 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103966312A (en) | 2014-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prescott et al. | Rapid detection of Cyprinid herpesvirus 3 in latently infected koi by recombinase polymerase amplification | |
| CN102181581A (en) | Ternary PCR (polymerase chain reaction) kit for canine distemper virus, enteritis parvovirus and Aleutian disease virus | |
| CN107012261A (en) | Ana 1 aviadenovirus A types and the dual EvaGreen real-time fluorescence quantitative PCRs detection primer of 2 types | |
| CN113046484B (en) | Primer probe, kit and method for detecting African swine fever virus p72 gene | |
| CN110699486A (en) | Colloidal gold visual detection method for micropterus salmoides iridovirus and probe used by same | |
| CN103966314B (en) | The structure of pig peripheral blood monokaryon lymphocyte PD-1 recombinant plasmid, gene abundance real-time detection method and application thereof | |
| CN111254225A (en) | Mandarin fish frog virus and rhabdovirus double PCR detection kit and detection method | |
| CN112899404B (en) | Nested-RAA detection primer pair for mandarin fish frog iridovirus as well as application and detection method thereof | |
| CN114592089A (en) | Triple TaqMan fluorescent quantitative PCR kit for simultaneously detecting three circovirus | |
| CN112359148B (en) | PCR primer group for rapidly detecting three fish viruses and application thereof | |
| CN103966313B (en) | Construction of pig peripheral bloodmononuclear lymphocytePD-L1 (programmed death-ligand1) recombinantplasmids, real-time gene abundance detection method and application of method | |
| CN105200014B (en) | Duck tembusu virus infection clones attenuated vaccine strain and its preparation method and application | |
| CN103397106B (en) | Hybridized snakehead fish rhabdovirus fluorescent quantificationally PCR detecting kit and detection method thereof | |
| CN103820481B (en) | Construction of PD-L2 recombinant plasmid in chicken peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application | |
| CN103966312B (en) | Construction of PD-L2 recombinant plasmid in porcine peripheral blood mononuclear lymphocytes, real-time detection method of gene abundance and its application | |
| CN103789335B (en) | Construction method of recombinant plasmid of PD-L1 (programmed death-ligand 1) in chicken peripheral blood mononuclear lymphocytes, real-time gene abundance detection method and application of detection method | |
| CN108842000A (en) | For identifying the primer sets of DAdV-3 and DAdV-A | |
| CN108998443B (en) | Goat testis fibroblast membrane system yeast cDNA library and construction method thereof | |
| CN112538460B (en) | Method for improving porcine circovirus proliferation | |
| Xu et al. | Cloning of the full-length cDNA of the gene encoding complement C5 from grass carp (Ctenopharyngodon idella) and its expression in different tissues by following grass carp reovirus infection | |
| CN103789432A (en) | Construction method of recombinant plasmid of PD-1 (programmed death-1) in chicken peripheral blood mononuclear lymphocytes, real-time gene abundance detection method and application of detection method | |
| CN110093359B (en) | Isolable nucleic acids containing CD3 promoter sequences and CAR sequences and applications | |
| CN107604099B (en) | LAMP (Loop-mediated isothermal amplification) detection primer group and kit for novel pigeon adenovirus | |
| CN113293235B (en) | Primer for frog virus detection and application thereof | |
| US12383613B2 (en) | Recombinant antigen and method of making the same, isolated polynucleotide of porcine reproductive and respiratory syndrome virus (PRRSV) and immunogenic composition including the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |